Global Artificial Cartilage Implant Market Growth 2023-2029
Cartilage is the semi-rigid specialized connective tissue performing a range of functions in the human body. It is designed to give support, bear weight and withstand tension, torsion, and bending. Cartilage can be classified as articular cartilage, elastic cartilage or fibrocartilage. Each cartilage type has its function e.g. elastic cartilage help in the maintenance of shape and structure of the ear and trachea. Cartilage also acts as a binder between two bones, permitting smooth motion between adjoining bony segments. Articular cartilage is found in synovial joints such as hip, knee, and elbow and is concerned with the mechanical and functional behavior. Osteoarthrosis is the one of the leading disability in the United States. About 80% of people over the age of 65+ in the United States are suffering from osteoarthrosis. Most commonly, distal interphalangeal, first carpometacarpal, and knee joints are affected leading to physical disability.
LPI (LP Information)' newest research report, the “Artificial Cartilage Implant Industry Forecast” looks at past sales and reviews total world Artificial Cartilage Implant sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Cartilage Implant sales for 2023 through 2029. With Artificial Cartilage Implant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Cartilage Implant industry.
This Insight Report provides a comprehensive analysis of the global Artificial Cartilage Implant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Cartilage Implant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artificial Cartilage Implant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Cartilage Implant and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Cartilage Implant.
The global Artificial Cartilage Implant market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Artificial cartilage implant market revenue is growing with a significant rate, this is attributed to increasing usage of these implants to repair degenerative cartilages. In addition to this, the artificial cartilage implants are useful in delaying total and partial joint replacement surgeries in elderly. Growing healthcare expenditure and increasing awareness regarding artificial cartilage implants is expected to boost the revenue growth of artificial cartilage implant market. Increasing number of new product launches also drives the market for artificial cartilage implants. However higher pricing of cartilage replacement surgeries along with the risk factors associated with artificial cartilages is expected to hamper the growth of the artificial cartilage implant market over the forecast period.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Cartilage Implant market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Upper Extremity Joints
Lower Extremity Joints
Vertebral Joints
Segmentation by application
Hospitals
Clinics
Ambulatory Surgical Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biomet
Azellon Cell Therapeutics
Anika Therapeutics
Johnson & Johnson
CellGenix
Medtronic
Stryker Corporation
Smith & Nephew
Key Questions Addressed in this Report
What is the 10-year outlook for the global Artificial Cartilage Implant market?
What factors are driving Artificial Cartilage Implant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Cartilage Implant market opportunities vary by end market size?
How does Artificial Cartilage Implant break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.